Literature DB >> 21744076

A new tool for grade II glioma studies: plotting cumulative time with quality of life versus time to malignant transformation.

Emmanuel Mandonnet, Hugues Duffau, Luc Bauchet.   

Abstract

Entities:  

Mesh:

Year:  2011        PMID: 21744076     DOI: 10.1007/s11060-011-0659-5

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


× No keyword cloud information.
  7 in total

1.  Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial.

Authors:  M J van den Bent; D Afra; O de Witte; M Ben Hassel; S Schraub; K Hoang-Xuan; P-O Malmström; L Collette; M Piérart; R Mirimanoff; A B M F Karim
Journal:  Lancet       Date:  2005 Sep 17-23       Impact factor: 79.321

2.  A new endpoint for the assessment of adjuvant therapy in postmenopausal women with operable breast cancer.

Authors:  R D Gelber; A Goldhirsch
Journal:  J Clin Oncol       Date:  1986-12       Impact factor: 44.544

3.  Inter- and intrapatients comparison of WHO grade II glioma kinetics before and after surgical resection.

Authors:  Emmanuel Mandonnet; Johan Pallud; Denys Fontaine; Luc Taillandier; Luc Bauchet; Philippe Peruzzi; Jacques Guyotat; Valérie Bernier; Marie-Hélène Baron; Hugues Duffau; Laurent Capelle
Journal:  Neurosurg Rev       Date:  2009-10-22       Impact factor: 3.042

4.  Quality of life self-reports from 200 brain tumor patients: comparisons with Karnofsky performance scores.

Authors:  N Mackworth; P Fobair; M D Prados
Journal:  J Neurooncol       Date:  1992-11       Impact factor: 4.130

5.  Low-grade gliomas: do changes in rCBV measurements at longitudinal perfusion-weighted MR imaging predict malignant transformation?

Authors:  Nasuda Danchaivijitr; Adam D Waldman; Daniel J Tozer; Christopher E Benton; Gisele Brasil Caseiras; Paul S Tofts; Jeremy H Rees; H Rolf Jäger
Journal:  Radiology       Date:  2008-04       Impact factor: 11.105

6.  Methyl-L-11C-methionine PET as a diagnostic marker for malignant progression in patients with glioma.

Authors:  Roland T Ullrich; Lutz Kracht; Anna Brunn; Karl Herholz; Peter Frommolt; Hrvoje Miletic; Martina Deckert; Wolf-Dieter Heiss; Andreas H Jacobs
Journal:  J Nucl Med       Date:  2009-11-12       Impact factor: 10.057

7.  Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas.

Authors:  Justin S Smith; Edward F Chang; Kathleen R Lamborn; Susan M Chang; Michael D Prados; Soonmee Cha; Tarik Tihan; Scott Vandenberg; Michael W McDermott; Mitchel S Berger
Journal:  J Clin Oncol       Date:  2008-03-10       Impact factor: 44.544

  7 in total
  5 in total

1.  Survey on current practice within the European Low-Grade Glioma Network: where do we stand and what is the next step?

Authors:  Emmanuel Mandonnet; Michel Wager; Fabien Almairac; Marie-Helene Baron; Marie Blonski; Christian F Freyschlag; Fabio Barone; Denys Fontaine; Johan Pallud; Monika Hegi; Catarina Viegas; Maria Zetterling; Giannantonio Spena; John Goodden; Geert-Jan Rutten; Luc Taillandier; Nicolas Foroglu; Amélie Darlix; Miran Skrap; Juan Martino; Gord von Campe; Caterina Madadaki; Etienne Gayat; Philip de Witt Hamer; Santiago Gil Robles; Silvio Sarubbo; Thomas Santarius; Lorenzo Bello; Marie-Therese Forster; Hugues Duffau
Journal:  Neurooncol Pract       Date:  2017-01-17

2.  Is there a response shift in generic health-related quality of life 6 months after glioma surgery?

Authors:  Asgeir Store Jakola; Ole Solheim; Sasha Gulati; Lisa Millgård Sagberg
Journal:  Acta Neurochir (Wien)       Date:  2016-12-07       Impact factor: 2.216

3.  Spatial distribution of malignant transformation in patients with low-grade glioma.

Authors:  Asgeir S Jakola; David Bouget; Ingerid Reinertsen; Anne J Skjulsvik; Lisa Millgård Sagberg; Hans Kristian Bø; Sasha Gulati; Kristin Sjåvik; Ole Solheim
Journal:  J Neurooncol       Date:  2020-01-09       Impact factor: 4.130

4.  Group-level stability but individual variability of neurocognitive status after awake resections of right frontal IDH-mutated glioma.

Authors:  Marion Barberis; Isabelle Poisson; Valentine Facque; Sophie Letrange; Cécile Prevost-Tarabon; Emmanuel Houdart; Sébastien Froelich; Richard Levy; Emmanuel Mandonnet
Journal:  Sci Rep       Date:  2022-04-12       Impact factor: 4.379

5.  Return to work following diagnosis of low-grade glioma: A nationwide matched cohort study.

Authors:  Isabelle Rydén; Louise Carstam; Sasha Gulati; Anja Smits; Katharina S Sunnerhagen; Per Hellström; Roger Henriksson; Jiri Bartek; Øyvind Salvesen; Asgeir Store Jakola
Journal:  Neurology       Date:  2020-06-15       Impact factor: 11.800

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.